April 4, 2018 8:56pm

CLLS closed down -$5.43 or -14.09% - Maintaining SELL

Offering is priced at $31.00 per ADS and the number of ADSs is 5,646,000



The closing of the offering is expected to occur on April 10, 2018, subject to customary closing conditions. The listing of the ordinary shares of Cellectis on Euronext Growth will be suspended on April 5, 2018 until the opening of trading on the NASDAQ market at 3:30 pm (Paris time)


Cellectis S.A. (ALCLS.PA) (CLLS) (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS announced a launch, subject to market conditions, of an underwritten public offering of $175 million of its American Depositary Shares (“ADS”), each representing one ordinary share of CLLS.

Cellectis expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the aggregate offering size.


Goldman Sachs & Co. LLC and Citigroup are acting as book-running managers for the offering. Barclays is also acting as a book-running manager. Nomura is acting as lead


NOTE: In particular, no public offering of the ADSs will be made in Europe.